← Open Payments lookup

ABEGAIL SUMAGUI: Open Payments

NPI 1245937366 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$342 in 13 payments from 7 companies in 2025. Trend: 2023 $223 · 2024 $641 · 2025 $342

Food & beverage: $342
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$82
E.R. Squibb & Sons, L.L.C.3$74
Teva Pharmaceuticals USA, Inc.2$51
Otsuka America Pharmaceutical, Inc.2$41
Janssen Pharmaceuticals, Inc1$32
Exact Sciences Corporation1$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$30

Products named: INGREZZA, COBENFY, ABILIFY MAINTENA, INVEGA SUSTENNA, Cologuard Collection Kit, CAPLYTA, AUSTEDO XR, UZEDY.

Industry payments across IL — which companies pay providers there.